Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Holiday destinations for Creature Sweethearts - 2Rediscovering Experience Through Excursions: Individual Travel Stories
- 3Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
- 415 skywatching events you won't want to miss in 2026
- 5Instructions to Boost Your True capacity with a Brain research Degree
- Major railway disruptions persist as Germany braces for more snow
- Excited visitors for NASA's moon launch jockey for prime views
- A Manual for Extravagant Vehicles Available in 2024
- NASA's Voyager 1 set to achieve historic distance from Earth
- Deaths reported in Lebanon as Israel and Hezbollah exchange attacks
- The Best 20 Tunes that Characterized an Age
- More people are addicted to marijuana, but fewer of them are seeking help, experts say
- Exclusive-Head of Pemex's production arm to step down in coming days, sources say
- A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.'
